• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public Calendar: June 24-28, 2013

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

June 24-28, 2013
FDA Official and TitleDateLocationOther FDA ParticipantsNon-FDA ParticipantsSubject
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs6/24/13Boston, MAN/AN/APanelist for “Cooperation Among Regulators: Impact on Stakeholders” at the Drug Information Association (DIA) 49th Annual Meeting, “Advancing Therapeutic Innovation and Regulatory Science”
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs6/27/13New York, NYN/AN/AAlexandria Summit “Oncology 2013” Panelist on Pediatric Drugs for Rare Diseases 
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs6/30/13Aspen, CON/AN/APanelist for “What’s Holding Back Medical Progress?” at the Aspen Ideas Festival
John M. Taylor, III, Counselor to the Commissioner and Acting Deputy Commissioner for Global Regulatory Operations and Policy6/24/13-6/28/13N/AN/AN/ANo Significant Meetings
Virginia Cox, Associate Commissioner for External Affairs6/24/13-6/28/13N/AN/AN/ANo Significant Meetings
Elizabeth H. Dickinson, Esq., Chief Counsel6/24/13-6/28/13Silver Spring, MDN/AN/ANo Significant Meetings
Bernadette Dunham, D.V.M., Ph.D., Director, Center for Veterinary Medicine6/26/13TeleconferenceMichael Oehlsen, Shena Arellano, Margaret Oeller, Brandi Robinson, Merton Smith, Steven Vaughn, Kevin Greenlees, William FlynnKornelia Grein, Isaura Duarte, Sabine Haubenreisser, Emer Cook, Janice Soreth, Jordi Torren, David MacKay, Nikolaus Kriz, Karen Quigley, Nicholas Jarrett (European Medicines Agency)Quarterly Meeting
Jesse Goodman, M.D., M.P.H., Chief Scientist6/25/13Washington, DCN/AHealth Advocacy CommunityInstitute of Medicine, Forum on Microbial Threats Briefing on Emerging Viral Diseases
Walter Harris, Deputy Commissioner for Operations and Chief Operating Officer6/24/13-6/28/13N/AN/AN/ANo Significant Meetings
Sally Howard, J.D., Deputy Commisioner for Policy, Planning and Legislation6/24/13-6/28/13N/AN/AN/ANo Significant Meetings 
Michael M. Landa, Director, Center for Food Safety and Applied Nutrition6/24/13-6/28/13N/AN/AN/ANo Significant Meetings
Peter Lurie, Acting Associate Commissioner for Policy and Planning6/24/13-6/28/13N/AN/AN/ANo Significant Meetings
Karen Midthun, M.D., Director, Center for Biologics Evaluation and Research6/24/13Boston, MASeveral FDA officials and staff membersN/ATown Hall Session at Drug Information Association Annual Meeting
Michele Mital, Acting Associate Commissioner for Legislation6/24/13-6/28/13N/AN/AN/ANo Significant Meetings
Melinda Plaiser, Acting Associate Commissioner for Regulatory Affairs6/24/13-6/28/13N/AN/AN/ANo Significant Meetings
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health6/24/13-6/28/13N/AN/AN/ANo Significant Meetings
William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research6/22/13-6/26/13Tucson, AZN/AN/APresented Abstract at Council Meeting at the Annual Teratology Society Meeting
Michael R. Taylor, J.D., Deputy Commissioner for Foods and Veterinary Medicine6/24/13-6/28/13N/AN/AN/ANo Significant Meetings
Mary Lou Valdez, Associate Commissioner for International Programs6/24/13-6/28/13N/AN/AN/ANo Significant Meetings
Jill Hartzler Warner, J.D., Acting Associate Commissioner for Special Medical Programs6/24/13-6/28/13N/AN/AN/ANo Significant Meetings
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research6/24/13-6/28/13N/AN/AN/ANo Significant Meetings
Mitchell R. Zeller, J.D., Director, Center for Tobacco Products6/24/13-6/28/13N/AN/AN/ANo Significant Meetings